7-130270750-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001869.3(CPA2):c.346G>A(p.Gly116Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,613,720 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001869.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CPA2 | NM_001869.3 | c.346G>A | p.Gly116Ser | missense_variant | 4/11 | ENST00000222481.9 | NP_001860.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CPA2 | ENST00000222481.9 | c.346G>A | p.Gly116Ser | missense_variant | 4/11 | 1 | NM_001869.3 | ENSP00000222481 | P1 | |
CPA2 | ENST00000480781.5 | n.363G>A | non_coding_transcript_exon_variant | 4/5 | 2 | |||||
CPA2 | ENST00000487259.5 | n.361G>A | non_coding_transcript_exon_variant | 4/7 | 2 | |||||
CPA2 | ENST00000416698.1 | c.340G>A | p.Gly114Ser | missense_variant, NMD_transcript_variant | 4/8 | 5 | ENSP00000395582 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152132Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251386Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135878
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1461588Hom.: 0 Cov.: 30 AF XY: 0.00000550 AC XY: 4AN XY: 727120
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152132Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74298
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 05, 2024 | The c.346G>A (p.G116S) alteration is located in exon 4 (coding exon 4) of the CPA2 gene. This alteration results from a G to A substitution at nucleotide position 346, causing the glycine (G) at amino acid position 116 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at